172 related articles for article (PubMed ID: 25651429)
1. Comparative effectiveness of treatments for newly diagnosed follicular non-Hodgkin lymphoma.
Messori A; Fadda V; Maratea D; Trippoli S
Leuk Lymphoma; 2015; 56(9):2728-30. PubMed ID: 25651429
[No Abstract] [Full Text] [Related]
2. Counterpoint: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?
Barr PM
Oncology (Williston Park); 2018 Aug; 32(8):404, 407-9. PubMed ID: 30153320
[No Abstract] [Full Text] [Related]
3. Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy.
Griffiths R; Gleeson M; Reyes C; Knopf K; Danese M
Am J Hematol; 2010 Dec; 85(12):963-7. PubMed ID: 20981680
[No Abstract] [Full Text] [Related]
4. Lenalidomide and R-CHOP in follicular lymphoma: where do we go from here?
Gordon LI
Lancet Haematol; 2018 Sep; 5(9):e381-e382. PubMed ID: 30172340
[No Abstract] [Full Text] [Related]
5. Rituximab maintenance improves overall survival of patients with follicular lymphoma-Individual patient data meta-analysis.
Vidal L; Gafter-Gvili A; Salles G; Bousseta S; Oberman B; Rubin C; van Oers MH; Fortpied C; Ghielmini M; Pettengell R; Witzens-Harig M; Dreger P; Vitolo U; Gomes da Silva M; Evangelista A; Li H; Freedman L; Habermann TM; Shpilberg O
Eur J Cancer; 2017 May; 76():216-225. PubMed ID: 28336303
[TBL] [Abstract][Full Text] [Related]
6. Does monocyte count have prognostic significance in cancer?
Tadmor T
Leuk Res; 2013 Oct; 37(10):1193-4. PubMed ID: 23953915
[No Abstract] [Full Text] [Related]
7. Association of VEGFA-2578 C>A polymorphism with clinicopathological aspects and outcome in follicular lymphoma patients.
de Mendonça GR; Brito AB; Rocha RM; Delamain MT; de Andrade Natal R; Soares FA; Colleoni GW; Souza CA; Vassallo J; Lima CS
Blood Cancer J; 2016 Aug; 6(8):e464. PubMed ID: 27564462
[No Abstract] [Full Text] [Related]
8. Hematology: The case against rituximab maintenance.
Cheson BD
Nat Rev Clin Oncol; 2009 Nov; 6(11):622-4. PubMed ID: 19861992
[No Abstract] [Full Text] [Related]
9. Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Watanabe R; Tomita N; Kishimoto K; Koyama S; Ogusa E; Ishii Y; Miyashita K; Matsuura S; Fujisawa S; Hattori Y; Takasaki H; Fujita A; Ohshima R; Kuwabara H; Hashimoto C; Fujimaki K; Sakai R; Ishigatsubo Y
Leuk Res; 2013 Oct; 37(10):1208-12. PubMed ID: 23927994
[TBL] [Abstract][Full Text] [Related]
10. Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: a multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group.
Provencio M; Cruz Mora MÁ; Gómez-Codina J; Quero Blanco C; Llanos M; García-Arroyo FR; de la Cruz L; Gumá Padró J; Delgado Pérez JR; Sánchez A; Alvarez Cabellos R; Rueda A;
Leuk Lymphoma; 2014 Jan; 55(1):51-5. PubMed ID: 23573825
[TBL] [Abstract][Full Text] [Related]
11. Hematology: Follicular lymphoma: maintenance therapy is (often) indicated.
Seymour JF
Nat Rev Clin Oncol; 2009 Nov; 6(11):624-6. PubMed ID: 19861993
[No Abstract] [Full Text] [Related]
12. Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma.
Kumar R; Galardy PJ; Dogan A; Rodriguez V; Khan SP
Pediatr Blood Cancer; 2011 Aug; 57(2):317-20. PubMed ID: 21462303
[TBL] [Abstract][Full Text] [Related]
13. [A case of follicular lymphoma of the duodenum treated with the combined therapy of anti-CD20 antibody and chemotherapy].
Isogai K; Yamamoto E; Yamaoka S; Tarasawa I; Murakami R; Morimoto I; Obata T; Mori M; Endo T; Imai K
Nihon Shokakibyo Gakkai Zasshi; 2006 Mar; 103(3):301-9. PubMed ID: 16688961
[No Abstract] [Full Text] [Related]
14. Impact of age on genetics and treatment efficacy in follicular lymphoma.
Alig S; Jurinovic V; Pastore A; Bararia D; Häbe S; Hellmuth JC; Kridel R; Gascoyne R; Schmidt C; Zöllner AK; Buske C; Dreyling M; Unterhalt M; Hiddemann W; Hoster E; Weigert O
Haematologica; 2018 Aug; 103(8):e364-e367. PubMed ID: 29545350
[No Abstract] [Full Text] [Related]
15. Chemotherapy: maintenance rituximab for relapsed follicular lymphoma.
Wrench D; Montoto S
Nat Rev Clin Oncol; 2010 Dec; 7(12):677-8. PubMed ID: 21116237
[No Abstract] [Full Text] [Related]
16. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial.
Watanabe T; Tobinai K; Wakabayashi M; Morishima Y; Kobayashi H; Kinoshita T; Suzuki T; Yamaguchi M; Ando K; Ogura M; Taniwaki M; Uike N; Yoshino T; Nawano S; Terauchi T; Hotta T; Nagai H; Tsukasaki K;
Lancet Haematol; 2018 Nov; 5(11):e520-e531. PubMed ID: 30389034
[TBL] [Abstract][Full Text] [Related]
17. [High-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma].
Provencio M; Fayad LE
Med Clin (Barc); 2008 Jan; 130(2):60-5. PubMed ID: 18221676
[No Abstract] [Full Text] [Related]
18. What is the best initial therapy for a patient with symptomatic low-grade follicular lymphoma?
Kenkre VP; Kahl BS
Cancer J; 2012; 18(5):383-9. PubMed ID: 23006941
[TBL] [Abstract][Full Text] [Related]
19. The optimal management of follicular lymphoma: an evolving field.
Ujjani C; Cheson BD
Drugs; 2013 Sep; 73(13):1395-403. PubMed ID: 23884816
[TBL] [Abstract][Full Text] [Related]
20. Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study.
Tilly H; Morschhauser F; Casasnovas O; Molina TJ; Feugier P; Gouill SL; Haioun C; Tournilhac O; Bouabdallah R; Gabarre J; Lamy T; Cabeçadas J; Becker S; Jardin F; Mounier N; Salles G;
Lancet Haematol; 2018 Sep; 5(9):e403-e410. PubMed ID: 30172345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
